Hugel Backs Physician-Led Research to Raise K-Aesthetics Profile
Hugel is funding physician-led research to build the clinical evidence base behind Korean aesthetic medicine as it competes globally, Korea Biomedical Review reports.
Topic
Botulinum Toxin
Topic
Botulinum Toxin
Hugel Sets 1 Trillion Won Sales Target Within Three Years
Hugel targets 1 trillion won in sales within three years, staking its growth plan on the Korean aesthetics maker's injectable por…
Hugel Names Taiwan a Key Growth Market for Letybo Aesthetic Push
Hugel is targeting Taiwan as a priority growth market for its botulinum toxin Letybo and its wider aesthetic portfolio, aiming to…
Scalp Botox for Hair Loss: Doctors Assess South Korea's Latest Trend
Botulinum toxin injected into the scalp is being marketed in South Korea for hair loss, but physicians warn the evidence base rem…
Ontario's Botox Boom Exposes Provider Divide
Demand for Botox and similar injectables is surging across Ontario, and CBC reports doctors and nurses remain divided over how th…